Zobrazeno 1 - 10
of 1 313
pro vyhledávání: ''
Publikováno v:
Rheumatology
Rheumatology, 2022, 61 (2), pp.873-873. ⟨10.1093/rheumatology/keab352⟩
Rheumatology, 2022, 61 (2), pp.873-873. ⟨10.1093/rheumatology/keab352⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515a3e08fba315f854aa70a07e8ee852
https://hal-amu.archives-ouvertes.fr/hal-03653472
https://hal-amu.archives-ouvertes.fr/hal-03653472
Autor:
Mathilde Cancel, Oana Pop, Alain Lortholary, C.B. Levaché, Daniel Pissaloux, Magali Provansal, Elsa Kalbacher, Rémy Largillier, Amélie Anota, Audrey Lardy-Cleaud, Jérôme Meunier, Christophe Louvet, Anne-Claire Hardy-Bessard, Aurélie Houlier, Marie-Ange Mouret-Reynier, Fabien Brocard, Benoit You, Anne Floquet, Cyril Abdeddaim, Aude-Marie Savoye, Isabelle Ray-Coquard, Alain Zannetti, Laurence Venat-Bouvet, Isabelle Treilleux, Olivier Tredan, Jean-Sebastien Frenel
Publikováno v:
Gynecologic Oncology
Gynecologic Oncology, 2022, 164 (1), pp.18-26. ⟨10.1016/j.ygyno.2021.09.024⟩
Gynecologic Oncology, 2022, 164 (1), pp.18-26. ⟨10.1016/j.ygyno.2021.09.024⟩
Objective To evaluate the efficacy and safety of regorafenib versus tamoxifen in platinum-sensitive ovarian cancer biological recurrence, defined by CA-125 increase without radiological (RECIST criteria) or symptomatic evidence of progression. Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442e0efad461a61c2ee12df093873312
https://hal.archives-ouvertes.fr/hal-03868128
https://hal.archives-ouvertes.fr/hal-03868128
Autor:
Margaux Garzaro, David Boutboul, B. Dunogué, Rémi Bertinchamp, Lionel Galicier, Frédéric Vandergeynst, Mirlinda Berisha, Maximilien Grall, Virginie De Wilde, Noémie Saada, Eric Oksenhendler, Jehane Fadlallah, Laurence Gérard, Lucas Maisonobe, Stephanie Guillet, M. Hie, Marion Malphettes, Lara Zafrani, Claire Fieschi, Louise Damian
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, In press, ⟨10.1111/bjh.17868⟩
British Journal of Haematology, Wiley, In press, ⟨10.1111/bjh.17868⟩
International audience; Idiopathic multicentric Castleman disease (iMCD) is a non-clonal inflammatory lymphoproliferative disorder of unknown origin. Recently, TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) em
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b94ec8633a6346e212ba269e07fea9
https://hal.sorbonne-universite.fr/hal-03524186
https://hal.sorbonne-universite.fr/hal-03524186
Autor:
Frédéric Galactéros, Sadaf Pakdaman, Elisa Domingues-Hamdi, Corinne Vasseur, Véronique Baudin-Creuza
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, 2022, 196 (1), pp.183-192. ⟨10.1111/bjh.17728⟩
British Journal of Haematology, Wiley, 2022, 196 (1), pp.183-192. ⟨10.1111/bjh.17728⟩
International audience; Alpha haemoglobin-stabilising protein (AHSP) is a key chaperone synthesised in red blood cell (RBC) precursors. Many studies have reported AHSP as a potential biomarker of various diseases. AHSP gene expression has been studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a1f6eae08336dff0c326358d1d28c4
https://www.hal.inserm.fr/inserm-03714110/document
https://www.hal.inserm.fr/inserm-03714110/document
Autor:
François Robin, Alexandre Tronchot, Adrien Rossetti, Pascal Guggenbuhl, Mickaël Ropars, Julien Maximen
Publikováno v:
Joint Bone Spine
Joint Bone Spine, 2022, 89 (1), pp.105260. ⟨10.1016/j.jbspin.2021.105260⟩
Joint Bone Spine, Elsevier Masson, 2022, 89 (1), pp.105260. ⟨10.1016/j.jbspin.2021.105260⟩
Joint Bone Spine, 2022, 89 (1), pp.105260. ⟨10.1016/j.jbspin.2021.105260⟩
Joint Bone Spine, Elsevier Masson, 2022, 89 (1), pp.105260. ⟨10.1016/j.jbspin.2021.105260⟩
International audience; BACKGROUND: Aneurysmal bone cyst (ABC) is a benign, locally aggressive tumour that arises predominantly in long bones and spine. Following the encouraging results of denosumab use in Giant Cell Tumors (GCT) and the histologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::562db48644fb8c9d5217134cf7c4b6d6
https://hal.science/hal-03369670
https://hal.science/hal-03369670
Autor:
Seock-Ah Im, Patrick Neven, John Crown, Rosa-Maria Espadero, Noelia Martínez, Yen-Shen Lu, Jonas Bergh, Thomas Bogenrieder, J. Alejandro Pérez-Fidalgo, Peter Schmid, Guy Jerusalem, Laura Schlieker, Serafin Morales, Dennis Chin-Lun Huang, Douglas Adamson, Javier Cortes, Anthony Gonçalves, Keun Seok Lee, Marie-Paule Sablin, Aleix Prat
Publikováno v:
Breast Cancer Research
Breast Cancer Research, 2021, 23 (1), pp.8. ⟨10.1186/s13058-020-01382-8⟩
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Scientia
Breast Cancer Research, 2021, 23 (1), pp.8. ⟨10.1186/s13058-020-01382-8⟩
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Scientia
Background Xentuzumab—a humanised IgG1 monoclonal antibody—binds IGF-1 and IGF-2, inhibiting their growth-promoting signalling and suppressing AKT activation by everolimus. This phase Ib/II exploratory trial evaluated xentuzumab plus everolimus a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3fb312f1fe2cc964111c140ba48f774
https://hal.science/hal-03630009
https://hal.science/hal-03630009
Autor:
Naomi P. Awaca-Uvon, Godefroy Kuyangisa-Simuna, Sébastien D. S. Pion, Jérémy T Campillo, Cédric B Chesnais, Michel Boussinesq, Jean Paul Tambwe, Gary J. Weil, Johnny Vlaminck
Publikováno v:
Parasites & Vectors
Parasites & Vectors, 2021, 14 (1), pp.310. ⟨10.1186/s13071-021-04814-2⟩
Parasites & Vectors, Vol 14, Iss 1, Pp 1-10 (2021)
Parasites & Vectors, 2021, 14 (1), pp.310. ⟨10.1186/s13071-021-04814-2⟩
Parasites & Vectors, Vol 14, Iss 1, Pp 1-10 (2021)
Background The impact of semiannual mass drug administration (MDA) with albendazole (ALB; 400 mg) alone on lymphatic filariasis (LF) and soil-transmitted helminth (STH) infections was assessed during two trials conducted from 2012 to 2018 in the Repu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72aed85ae8ee27ae88aa892b1c8faa3b
https://hal.science/hal-03906718/document
https://hal.science/hal-03906718/document
Autor:
Farès Moustafa, Bruno Pereira, Jeannot Schmidt, Frédéric Dutheil, Carolyne Croizier, Jean-Baptiste Bouillon-Minois, Nicolas Peschanski, Julien S. Baker, Justin Outrey
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2021, 11 (1), ⟨10.1038/s41598-021-94727-y⟩
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.15275. ⟨10.1038/s41598-021-94727-y⟩
Scientific Reports, 2021, 11 (1), pp.15275. ⟨10.1038/s41598-021-94727-y⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Nature Publishing Group, 2021, 11 (1), ⟨10.1038/s41598-021-94727-y⟩
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.15275. ⟨10.1038/s41598-021-94727-y⟩
Scientific Reports, 2021, 11 (1), pp.15275. ⟨10.1038/s41598-021-94727-y⟩
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Non-traumatic intracranial bleeding (NTIB), comprising subarachnoid hemorrhage (SAH) and intra-cranial bleeding (ICH) is a significant public health concern. Tranexamic acid (TXA) is a promising treatment with benefits yet to be fully demonstrated. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fce10d3946edfb1409ee78ea282ad6a5
https://hal.archives-ouvertes.fr/hal-03403120
https://hal.archives-ouvertes.fr/hal-03403120
Autor:
Marine Perriguey, Jan-Patrick Stellmann, Adil Maarouf, Pierre Durozard, Sarah Demortiere, Jean Pelletier, Audrey Rico, Clemence Boutiere, Bertrand Audoin
Publikováno v:
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1115. ⟨10.1212/NXI.0000000000001115⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1115. ⟨10.1212/NXI.0000000000001115⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Background and ObjectivesTo determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).MethodsThis prospective observational study included all consecutive PwMS receiving RTX a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a83941d2bcccd9d9a49e71db9a3b358
https://amu.hal.science/hal-03537471
https://amu.hal.science/hal-03537471
Autor:
Marion Schmitt, Ghislaine Prévot, Pierre Couppié, Jean-Marie Loreau, Magalie Demar, Guillaume Frechard, Marine Ginouves, Kim M. Henry, Miguel Hernandez, Pierre-Antoine Blanc, Romain Blaizot, A. Mayet, Nathalie André
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 2021, 15 (11), pp.e0009938. ⟨10.1371/journal.pntd.0009938⟩
PLoS Neglected Tropical Diseases, Vol 15, Iss 11, p e0009938 (2021)
PLoS Neglected Tropical Diseases, 2021, 15 (11), pp.e0009938. ⟨10.1371/journal.pntd.0009938⟩
PLoS Neglected Tropical Diseases, Vol 15, Iss 11, p e0009938 (2021)
Background Cutaneous Leishmaniasis (CL) is endemic in French Guiana but cases are usually sporadic. An outbreak signal was issued on May 15th 2020 with 15 suspected cases after a military training course in the rainforest. An outbreak investigation w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ca899d7c3b4488ab7789fd3292d582
https://www.hal.inserm.fr/inserm-03651901
https://www.hal.inserm.fr/inserm-03651901